Applications

Treat type 2 diabetes. It is a DPP-4 inhibitor, which can reduce blood sugar by inhibiting dipeptidyl peptidase 4, increasing the level of glucagon-like polypeptide (GLP-1) in the body. It can reduce fasting blood sugar and postprandial blood sugar, mainly lowering postprandial blood sugar.

Technical specification

USP, EP

Packaging

Packaging is confirmed with the quotation.

On a small screen, scroll the technical table horizontally.

Published reference specifications. Confirm the current grade, SDS / TDS / COA, packaging and delivery terms with your quotation.